A phase 1 study of intra-arterial CBL0137 in extremity melanomas and sarcomas
The historic restrictions of standard regional therapies may be overcome with IA CBL0137, and this treatment is potentially applicable to a wide range of cancers beyond the extremities.
Authors
- Katerina V. Gurova (ORCID: https://orcid.org/0000-0001-9189-0712)
- Joseph J. Skitzki (ORCID: https://orcid.org/0000-0002-3689-2843)
- Andrei V. Gudkov (ORCID: https://orcid.org/0000-0003-2548-0154)
- Andrei A. Purmal
- Minhyung Kim (ORCID: https://orcid.org/0000-0002-5628-1062)
- Daniel T. Fisher
- John M. Kane (ORCID: https://orcid.org/0000-0002-6472-7300)
- Han Yu
- Kayla Catalfamo
- Garin Tomaszewski
- Michael Petroziello
Institutions
- Roswell Park Comprehensive Cancer Center (US)
- Cleveland Clinic (US)
- University at Buffalo, State University of New York (US)
Publication Details
- Journal
- Surgical Oncology
- Published
- 2025-06-07
- DOI
- https://doi.org/10.1016/j.suronc.2025.102243
- Citations
- 2
- Primary Topic
- Angiogenesis and VEGF in Cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- Roswell Park Cancer Institute
- National Cancer Institute